Laboratory of Pharmacognosy, College of Pharmacy, Chungbuk National University, Cheongju, Korea.
Planta Med. 2011 Jul;77(10):1020-3. doi: 10.1055/s-0030-1270712. Epub 2011 Feb 3.
Fraxinus rhynchophylla showed significant inhibitory activity on adipocyte differentiation in the 3T3-L1 preadipocyte cell line as assessed by measuring fat accumulation using Oil Red O staining. Further fractionation led to the isolation of two secoiridoids, oleuropein and hydroxyframoside B. Hydroxyframoside B significantly reduced fat accumulation and triglyceride content in differentiated 3T3-L1 cells without affecting cell viability, whereas oleuropein showed little effect. Further studies with interval treatment demonstrated that hydroxyframoside B exerted inhibitory activity on adipocyte differentiation when treated within 2 days (days 0-2) after differentiation induction. In addition, hydroxyframoside B significantly blocked the induction of adipogenic transcription factors such as C/EBP α, C/EBP β, and PPAR γ. Taken together, these results suggest that hydroxyframoside B inhibited early/middle stage of adipogenic differentiation, in part, via inhibition of C/EBP α, C/EBP β, and PPAR γ-dependent pathways.
水曲柳通过油红 O 染色检测脂肪积累来评估,对 3T3-L1 前体脂肪细胞系中的脂肪细胞分化表现出显著的抑制活性。进一步的分离得到了两种裂环烯醚萜类化合物,橄榄苦苷和羟基法呢醇 B。羟基法呢醇 B 可显著减少分化的 3T3-L1 细胞中的脂肪积累和甘油三酯含量,而不影响细胞活力,而橄榄苦苷则几乎没有效果。进一步的间隔处理研究表明,羟基法呢醇 B 在诱导分化后 2 天(第 0-2 天)内处理时,对脂肪细胞分化表现出抑制活性。此外,羟基法呢醇 B 可显著阻断脂肪生成转录因子如 C/EBPα、C/EBPβ和 PPARγ的诱导。综上所述,这些结果表明,羟基法呢醇 B 通过抑制 C/EBPα、C/EBPβ 和 PPARγ 依赖的途径,抑制了脂肪生成的早期/中期分化。